Hammad Bhatti, MD
Critical Care Medicine · Orlando, FLNPI 1285953877
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $39,640 of the $41,356 with a category attached, or 95.9%. Boehringer Ingelheim accounts for 98.3% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $13,783 and has fallen 94.4% since, to $771 in 2025. Among critical care medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $656.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$41K
- AstraZeneca$228
- GSK$196
- Boston Scientific$61
- Insmed, Inc.$52
- United Therapeutics Corporation$44
- plus $127 from 5 others
What the payments were for
- Speaking & faculty fees$39,64096%
- Food & beverage$1,7164%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 34 | $40,647 |
| AstraZeneca | 7 | $228 |
| GSK | 12 | $196 |
| Boston Scientific | 1 | $61 |
| Insmed, Inc. | 2 | $52 |
| United Therapeutics Corporation | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Sanofi | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Verona Pharma, Inc. | 1 | $20 |
| Grifols USA, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,356 in reported general payments places this provider in the 95th percentile of 618 critical care medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Orlando
- Louis GuzziOrlando$635K
- Omid ZadOrlando$325K
- Charles HunleyOrlando$116K
- Martin ZamoraOrlando$44K
- Dmitriy ZubkusOrlando$22K
- Amay ParikhOrlando$8K
- Sundeep GulianiOrlando$6K
- Fortune AlabiKissimmee$587K
- Debabrata BandyopadhyayTampa$398K
- Fred UmehKissimmee$371K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.